Supplementary Figure S6 from PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts
Year: 2025
Type: supplementary-materials
Abstract: Progression-free survival stratified by baseline PSA levels in separate study cohorts
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4408537680
